-
Innovation Ranking
Innovation Ranking – Tonix Pharmaceuticals Holding Corp
Tonix Pharmaceuticals Holding Corp (Tonix) is a developer of pharmaceutical products to address public health challenges. The company offers pharmaceutical products and treatments for disorders of the central nervous system including fibromyalgia, post traumatic stress disorder and episodic tension-type headache. Its products include oral formulation, smallpox vaccine, disintegrating sublingual tablets and tonmya. Tonix’s tonmya is a lead product candidate, designed as a bedtime treatment for post traumatic stress disorder. Its disintegrating sublingual tablets contain a dose and formulation of cyclobenzaprine...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TNX-1900 in Autism Spectrum Disorder (ASD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TNX-1900 in Autism Spectrum Disorder (ASD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TNX-1900 in Autism Spectrum Disorder (ASD) Drug Details: Oxytocin...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TNX-1900 in Migraine
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TNX-1900 in Migraine report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TNX-1900 in Migraine Drug Details: Oxytocin (TI-001) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TNX-1900 in Binge Eating Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TNX-1900 in Binge Eating Disorder report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TNX-1900 in Binge Eating Disorder Drug Details: Oxytocin (TI-001) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TNX-1900 in Social Anxiety Disorder (SAD/Social Phobia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TNX-1900 in Social Anxiety Disorder (SAD/Social Phobia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TNX-1900 in Social Anxiety Disorder (SAD/Social Phobia) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – INBRX-106 in Adenocarcinoma Of The Gastroesophageal Junction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - INBRX-106 in Adenocarcinoma Of The Gastroesophageal Junction report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. INBRX-106 in Adenocarcinoma Of The Gastroesophageal Junction Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tonmya in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tonmya in Alzheimer's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tonmya in Alzheimer's Disease Drug Details: TNX-102 SL (cyclobenzaprine hydrochloride, Tonmya) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tonmya in Fibromyalgia (Fibromyalgia Syndrome)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tonmya in Fibromyalgia (Fibromyalgia Syndrome) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tonmya in Fibromyalgia (Fibromyalgia Syndrome) Drug Details: TNX-102 SL (cyclobenzaprine...
-
Product Insights
Post-Traumatic Stress Disorder (PTSD) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Post-Traumatic Stress Disorder (PTSD) Clinical Trial Report Overview A total of 704 post-traumatic stress disorder (PTSD) clinical trials were conducted as of January 2024. The PTSD clinical trial report provides a comprehensive understanding of the PTSD clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor type and the prominent sponsors associated with the trials. Key Regions ·       North...